Literature DB >> 33829531

Low circulation of Influenza A and coinfection with SARS-CoV-2 among other respiratory viruses during the COVID-19 pandemic in a region of southern Brazil.

Ana Karolina Antunes Eisen1, Juliana Schons Gularte1, Meriane Demoliner1, Vyctoria Malayhka de Abreu Goés Pereira1, Fágner Henrique Heldt1, Micheli Filippi1, Paula Rodrigues de Almeida1, Alana Witt Hansen1, Juliane Deise Fleck1, Fernando Rosado Spilki1.   

Abstract

With the arrival of coronavirus disease 2019 (COVID-19) in Brazil in February 2020, several preventive measures were taken by the population aiming to avoid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection including the use of masks, social distancing, and frequent hand washing then, these measures may have contributed to preventing infection also by other respiratory viruses. Our goal was to determine the frequencies of Influenza A and B viruses (FLUAV/FLUBV), human mastadenovirus C (HAdV-C), Enterovirus 68 (EV-68), and rhinovirus (RV) besides SARS-CoV-2 among hospitalized patients suspect of COVID-19 with cases of acute respiratory disease syndrome (ARDS) in the period of March to December 2020 and to detect possible coinfections among them. Nucleic acid detection was performed using reverse-transcription quantitative polymerase chain reaction (RT-qPCR) in respiratory samples using naso-oropharyngeal swabs and bronchoalveolar lavage. A total of 418 samples of the 987 analyzed (42.3%) were positive for SARS-CoV-2, 16 (1.62%) samples were positive for FLUAV, no sample was positive for FLUBV or EV-68, 67 (6.78%) samples were positive for HAdV-C, 55 samples were positive for RV 1/2 (26.3%) and 37 for RV 2/2 (13.6%). Coinfections were also detected, including a triple coinfection with SARS-CoV-2, FLUAV, and HAdV-C. In the present work, a very low frequency of FLUV was reported among hospitalized patients with ARDS compared to the past years, probably due to preventive measures taken to avoid COVID-19 and the high influenza vaccination coverage in the region in which this study was performed.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ARDS; COVID-19; EV-68; HAdV-C; coinfection; influenza; rhinovirus

Year:  2021        PMID: 33829531     DOI: 10.1002/jmv.26975

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Investigating the human rhinovirus co-infection in patients with asthma exacerbations and COVID-19.

Authors:  Abdullah Al-Dulaimi; Ahmad R Alsayed; Mohammed Al Maqbali; Malek Zihlif
Journal:  Pharm Pract (Granada)       Date:  2022-05-02

2.  Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease.

Authors:  Pavel Iša; Blanca Taboada; Rodrigo García-López; Celia Boukadida; José Ernesto Ramírez-González; Joel Armando Vázquez-Pérez; Alejandra Hernández-Terán; José Ángel Romero-Espinoza; José Esteban Muñoz-Medina; Concepción Grajales-Muñiz; Alma Rincón-Rubio; Margarita Matías-Florentino; Alejandro Sanchez-Flores; Edgar Mendieta-Condado; Gisela Barrera-Badillo; Susana López; Lucía Hernández-Rivas; Irma López-Martínez; Santiago Ávila-Ríos; Carlos F Arias
Journal:  BMC Infect Dis       Date:  2022-10-19       Impact factor: 3.667

Review 3.  Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis.

Authors:  Thi Loi Dao; Van Thuan Hoang; Philippe Colson; Matthieu Million; Philippe Gautret
Journal:  J Clin Virol Plus       Date:  2021-08-09

4.  Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.

Authors:  Clément Fage; Mathilde Hénaut; Julie Carbonneau; Jocelyne Piret; Guy Boivin
Journal:  Viruses       Date:  2022-02-15       Impact factor: 5.048

5.  Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses.

Authors:  Lubna Pinky; Hana M Dobrovolny
Journal:  Front Microbiol       Date:  2022-03-11       Impact factor: 5.640

6.  Sharp decline in rates of community respiratory viral detection among NIH Clinical Center patients during the COVID-19 pandemic.

Authors:  Michele Woolbert; Christine Spalding; Ninet Sinaii; Brooke K Decker; Tara N Palmore; David K Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-18       Impact factor: 6.520

7.  Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection.

Authors:  Ivelina Trifonova; Iva Christova; Iveta Madzharova; Svetla Angelova; Silvya Voleva; Ralitsa Yordanova; Tatiana Tcherveniakova; Stefka Krumova; Neli Korsun
Journal:  Front Public Health       Date:  2022-09-02

Review 8.  The effects of the COVID-19 pandemic on community respiratory virus activity.

Authors:  Eric J Chow; Timothy M Uyeki; Helen Y Chu
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.